All 2026 dates on sale. Register before December 31!
In this update, you’ll learn about:
Aesthetic medicine is a rapidly growing field, with non-invasive procedures accounting for approximately 80% of all treatments performed. For new providers, the typical entry pathway begins with mastering the most common procedures — neurotoxin and dermal filler injections — before expanding into energy-based devices (lasers, RF microneedling) and more advanced biostimulatory treatments (PLLA, CaHA).
Most physicians achieve competency in basic neurotoxins in 3-6 months, after treating 50+ patients. The challenge is not just learning the technique, but understanding the science behind the products. This is where this month’s roundup is particularly valuable. The new head-to-head neurotoxin comparison data, for example, allows you to move beyond the brand you trained on and make informed choices based on duration, responder rates, and patient goals. Similarly, understanding the evidence behind combination therapies like RF microneedling and PLLA allows you to build sophisticated, high-value treatment plans that deliver superior results.
For a structured foundation in the core procedures, IAPAM Botox Training Comparison Page.
The Takeaway for New Practitioners: Once you have foundational skills, the next step is learning to make evidence-based decisions between the tools available to you. This month’s research provides the data to do that, moving beyond brand marketing to clinical substance. substance.
One of the most practically useful publications of the month was a systematic review comparing all six FDA-approved botulinum toxin A formulations across 82 studies.
This analysis arrives as the neurotoxin market is more crowded than ever. There are now seven FDA-approved neuromodulators in the U.S., with an eighth (trenibotulinumtoxinE) in Phase 3 trials.
The Takeaway: For the first time, a systematic review compares all six FDA-approved neurotoxins, giving you a data-informed starting point for product selection beyond brand familiarity.
A prospective randomized study showed that PLLA was successfully delivered through the microchannels created by RF microneedling, producing significant improvements in wrinkle scores and dermal thickness on ultrasound, without causing lipolysis (fat loss).
The Takeaway: This study confirms that RF microneedling enhances PLLA delivery and improves skin laxity, giving you an evidence-based protocol for combining these two modalities.
A study in the Journal of Cosmetic Dermatology found that PLLA produced statistically significant improvements in wrinkle severity and midface volume, with 65-72% of patients achieving treatment success at six months. Ultrasound imaging confirmed increased tissue density and signs of new collagen formation.
The Takeaway: This study confirms PLLA’s efficacy and provides biological evidence of neocollagenesis, useful for patient education.
A paper on an anatomically guided, multilayered approach to HA filler placement described a technique involving targeted injection at multiple tissue depths to restore volume in a way that more closely replicates natural facial anatomy.
The Takeaway: This technique can improve outcomes and reduce risks, representing a next-level skill for injectors to aspire to.
New data shows that patients on GLP-1 medications lose an average of 7% of midfacial volume for every 10 kilograms (22 pounds) of total body weight lost.
A recent survey found that 67% of facial plastic surgeons reported now seeing more patients with GLP-1-related facial changes, signaling a much larger opportunity for non-invasive providers.
The Takeaway: New data quantifies GLP-1-related facial volume loss, creating a significant opportunity for non-invasive providers to intercept these patients early.
The same survey also found that 57% of facial plastic surgeons reported seeing more patients under the age of 30. For non-invasive providers, the opportunity is in neurotoxins for early line prevention, medical-grade skincare, and light chemical peels.
The Takeaway: The trend of patients under 30 seeking preventative treatments is growing, representing a key demographic for building long-term practice loyalty.
A new umbrella review confirms that collagen supplements provide meaningful improvements in skin elasticity and hydration, but found limited and inconsistent evidence for wrinkle reduction.
The Takeaway: This landmark review provides a clear, evidence-based answer to a common patient question, building trust and capturing search interest.
A recent survey shows that only 7% of respondents would stop their aesthetic treatments entirely in a recession. The AAFPRS projects a 19% increase in facial procedures in 2025, with non-invasive treatments accounting for 80% of all procedures.
The Takeaway: Data shows the aesthetics market has strong structural demand, making it a stable business to enter.
The Takeaway: State-level regulations are evolving, and social media marketing carries real regulatory risk. Build compliance review into your practice calendar.
Industry data indicates that retail product sales can account for approximately 20% of total medical spa revenue.
The Takeaway: A focused, evidence-based skincare offering can meaningfully improve practice profitability without additional clinical time.
February 2026 was a month of grounding. The clinical studies, demographic surveys, and regulatory developments covered here provide the evidence needed to act on the trends that have been building for the past year. For physicians and nurse practitioners new to aesthetic medicine, this is the kind of information that separates confident, credible providers from those who are simply following trends.
To stay at the forefront of this evolving field, consider becoming a Certified Aesthetic Provider™ (CAP). The IAPAM offers comprehensive, CME-accredited training in all aspects of aesthetic medicine, from injectables to regenerative therapies. Enroll in the CAP program today and demonstrate your commitment to the highest standards of care.
Which neurotoxin should I start with?
There is no single correct answer. For new practitioners, starting with the formulation you received training on is appropriate. As your practice grows, the new comparative data can help you match product characteristics to specific patient goals.
How do I approach a patient on a GLP-1 medication?
Begin with a thorough consultation. Use the 7% per 10kg volume loss metric to set realistic expectations. Prioritize biostimulatory injectables (PLLA, CaHA) over HA fillers for structural support.
What should I tell patients about collagen supplements?
The new umbrella review supports telling patients that collagen supplements have credible evidence for improving skin elasticity and hydration, but not for wrinkle reduction.
Is the aesthetics market a stable business to enter?
The data suggests yes. The market has demonstrated resilience through economic downturns, and the vast majority of consumers treat their treatments as a recurring priority.
How do I know if my social media content is compliant?
If your posts reference specific prescription products by brand name without disclosing risks, they may be subject to OPDP enforcement. The safest approach is to focus on your practice and general education. When in doubt, consult a healthcare attorney.
Earn your certification and designation as trusted Certified Aesthetic Provider™ (CAP) and show your patients your commitment to the highest standards in training and care.
From Botox® and fillers to PRP, PDO threads, chemical peels and more, this is your one stop shop for CME-accredited training from an internationally-recognized association with 20 years of aesthetic medicine excellence.
References:
Contains: Emerging trends, expert discussions, recommendations, technique comparisons… and more!